Market Overview - The broader equity markets experienced a recovery after a significant sell-off, particularly driven by technology stocks like NVIDIA and Broadcom [1] - Bitcoin rebounded after dropping to $60,062.00, indicating a shift in investor sentiment towards risk-off strategies [1][2] Financial Sector Insights - The finance sector faces latent threats from AI and disappointing retail sales data, contributing to market volatility [2] - Investors are adopting a "wait-and-see" approach, focusing on "cash cow" stocks that offer higher returns [2] Key Financial Metrics - Return on Equity (ROE) is highlighted as a crucial metric for assessing a company's profitability and financial health [3][4] - A high ROE indicates effective reinvestment of cash at high rates of return, distinguishing profit-generating companies from less efficient ones [3][4] Stock Screening Criteria - Stocks are screened based on parameters such as Cash Flow greater than $1 billion and ROE exceeding industry averages [5] - Additional criteria include Price/Cash Flow lower than industry averages and Return on Assets (ROA) greater than industry benchmarks [6] Selected Stocks - Alcoa Corporation (AA): Engaged in mining and electricity generation, with a trailing four-quarter earnings surprise of 44.5% and a Zacks Rank 1 [7][8] - Globe Life Inc. (GL): An insurance holding company with a Zacks Rank 2 and a focus on life and supplemental health insurance [9][10] - Banco Bilbao Vizcaya Argentaria, S.A. (BBVA): Provides banking and asset management services, with a long-term earnings growth expectation of 12% and a Zacks Rank 1 [10][11] - The TJX Companies, Inc. (TJX): A leading off-price retailer with a long-term earnings growth expectation of 10.2% and a Zacks Rank 2 [12][13] - TE Connectivity plc (TEL): A global technology company focused on connectivity solutions, with a long-term earnings growth expectation of 12% and a Zacks Rank 1 [14][15]

Core Viewpoint - CNO Financial Group reported strong financial performance in 2025, exceeding guidance with significant growth in operating earnings, sales, and capital position, while maintaining a focus on agent productivity and navigating macroeconomic uncertainties. Financial Performance - Operating earnings per diluted share were $4.40, reflecting an 11% increase, driven by strong insurance product margins and investment performance [2] - The company returned $386 million to shareholders, including $320 million in share buybacks, while raising its quarterly common stock dividend for the 13th consecutive year [1][6] - Operating return on equity (ROE) improved to 11.4% excluding significant items, up from a 10% run rate in 2024 [13] Sales and Production Growth - CNO achieved record total new annualized premium (NAP) growth of 15%, supported by 14 consecutive quarters of sales growth and an increase in producing agent count [3][7] - In the consumer division, life NAP increased by 10%, with direct-to-consumer life sales up 20%, benefiting from technology-driven productivity enhancements [8] - The worksite division reported record insurance sales up 15% for the full year, marking the second consecutive year of record production [10] Capital Position and Investment Strategy - The company holds a strong capital position with a risk-based capital (RBC) ratio of 380% and $31 billion in invested assets, 97% of which are investment grade [6][19] - CNO plans to continue a three-year technology modernization initiative totaling approximately $170 million, with $75 million expected in 2026 [5][21] - New investments in the quarter totaled about $1.6 billion, with an average rating of single-A and an average duration of six years [17] 2026 Outlook - Management expects operating EPS of $4.25 to $4.45 and free cash flow of $200 million to $250 million for 2026, assuming a stable macro environment [5][20] - The company anticipates continued growth in producing agent count while emphasizing productivity as a primary focus [22] - CNO expects ongoing pressure on the Medicare Advantage market but strength in Medicare Supplement sales [23]

Core Viewpoint - Unum Group is a significant player in the insurance industry, particularly in the Accident and Health sector, offering various insurance products and services while competing with major insurers [1] Financial Performance - On February 5, 2026, Unum reported an earnings per share (EPS) of $1.92, which was below the estimated $2.11, resulting in a negative EPS surprise of 9.07% [2][6] - The EPS decreased from $2.03 in the same quarter the previous year, indicating a downward trend in earnings performance [2] - Unum's revenue for the quarter was approximately $3.24 billion, slightly missing the estimated $3.29 billion, but it has surpassed consensus revenue estimates in two of the last four quarters [3][6] Financial Ratios - Unum's price-to-earnings (P/E) ratio is around 14.11, suggesting a moderate market valuation of its earnings [4][6] - The price-to-sales ratio of 0.98 indicates that investors are paying less than one dollar for every dollar of sales [4] - The enterprise value to sales ratio of 1.24 reflects the company's total valuation relative to its sales [4] Liquidity and Debt Management - Unum maintains a strong liquidity position with a current ratio of approximately 2.33, indicating its ability to cover short-term liabilities [5] - The debt-to-equity ratio of roughly 0.34 shows a moderate level of debt compared to equity, suggesting a balanced financial structure [5] - The company's earnings yield of about 7.09% offers insight into the return on investment [5]

Core Insights - Aflac Incorporated will have President Virgil R. Miller participate in a fireside chat at the UBS Financial Services Conference on February 11, 2026, at 9:40 a.m. ET, which will be webcast live [1] Company Overview - Aflac Incorporated is a Fortune 500 company that has provided financial protection for over 70 years to millions of policyholders through its subsidiaries in the U.S. and Japan [2] - In the U.S., Aflac is the leading provider of supplemental health insurance products, while in Japan, Aflac Life Insurance Japan is the top provider of cancer and medical insurance based on policies in force [2] - The company has been recognized as one of the World's Most Ethical Companies for 19 consecutive years and has been included in Fortune's World's Most Admired Companies for 24 years [2] - Aflac became a signatory of the Principles for Responsible Investment in 2021 and has been part of the Dow Jones Sustainability North America Index for 11 years [2] Event Information - A replay of the presentation will be available within 24 hours after the live event [2]

Company Overview - Chubb Limited, formerly known as ACE Limited, is one of the world's largest providers of property and casualty (P&C) insurance and reinsurance, with a market capitalization of $86 billion [12] - The company has diversified through acquisitions into various specialty lines, including marine, medical risk, excess property, environmental, and terrorism insurance, and operates in 54 countries and territories [12] Investment Ratings - Chubb has a Zacks Rank of 3 (Hold) and a VGM Score of B, indicating a solid position but not a strong buy [13] - The Value Style Score is also rated B, supported by attractive valuation metrics such as a forward P/E ratio of 11.62, which may appeal to value investors [13] Earnings Estimates - In the last 60 days, five analysts have revised their earnings estimates higher for fiscal 2025, with the Zacks Consensus Estimate increasing by $0.39 to $24.10 per share [13] - Chubb has an average earnings surprise of +13.4%, suggesting a positive trend in earnings performance [13] Investment Consideration - With a solid Zacks Rank and top-tier Value and VGM Style Scores, Chubb is recommended to be on investors' short lists for potential investment opportunities [14]

Company Overview - Globe Life Inc. (GL) is a Texas-based financial services holding company valued at $11.3 billion, providing individual life insurance, supplemental health insurance, annuities, and related products through its subsidiaries [1] - The company primarily serves middle- and lower-middle-income Americans and has over 17 million policies in force, making it one of the larger life insurers in the United States [1] Earnings Expectations - Analysts expect GL to report a profit of $3.44 per share on a diluted basis for fiscal fourth-quarter earnings for 2025, representing a 9.6% increase from $3.14 per share in the same quarter last year [2] - For FY2025, analysts project GL's EPS to be $14.58, up 17.9% from $12.37 in fiscal 2024, with an expected rise to $15.04 in fiscal 2026, reflecting a 3.2% year-over-year increase [3] Stock Performance - GL stock has gained 24.4% over the past year, outperforming the S&P 500 Index's 17.7% gains and the Financial Select Sector SPDR Fund's 14.9% gains during the same period [4] - On December 11, shares of Globe Life increased by 2.7% after TD Cowen raised its price target to $199 from $182, maintaining a "Buy" rating and including the stock in its Best Ideas 2026 list [5] Analyst Ratings - The consensus opinion on GL stock is somewhat bullish, with a "Moderate Buy" rating overall; out of 13 analysts, eight recommend a "Strong Buy," two suggest a "Moderate Buy," and four give a "Hold" [6] - The average analyst price target for GL is $167, indicating a potential upside of 17.6% from current levels [6]

Core Viewpoint - Aflac Incorporated is set to release its fourth quarter 2025 financial results on February 4, 2026, with a subsequent conference call scheduled for February 5, 2026, to discuss these results and answer questions from investors [1][2]. Company Overview - Aflac Incorporated is a Fortune 500 company that has provided financial protection for over seven decades to millions of policyholders through its subsidiaries in the U.S. and Japan [3]. - In the U.S., Aflac is the leading provider of supplemental health insurance products, while in Japan, Aflac Life Insurance Japan is the top provider of cancer and medical insurance based on policies in force [3]. - The company has been recognized for its ethical practices, being included in the World's Most Ethical Companies by Ethisphere for 19 consecutive years and Fortune's World's Most Admired Companies for 24 years [3]. - Aflac became a signatory of the Principles for Responsible Investment (PRI) in 2021 and has been part of the Dow Jones Sustainability North America Index for 11 years [3].

Core Viewpoint - Globe Life Inc. has established Globe Life Re Ltd. as a Bermuda Class C insurer to provide reinsurance support for its affiliated insurance entities [1][3]. Group 1: Formation and Licensing - Globe Life Re Ltd. is licensed as a Bermuda Class C insurer [1]. - The new entity will engage in affiliated quota share reinsurance business, assuming a proportional share of risk on specified insurance policies [3]. Group 2: Regulatory Oversight and Transactions - All arrangements with Globe Life Re will be conducted on an arm's length basis and will be subject to appropriate regulatory oversight [3]. - The first reinsurance transaction has been executed in line with Globe Life Re's business plan [3]. Group 3: Company Overview - Globe Life Inc. has several insurance subsidiaries, including American Income Life Insurance Company, Family Heritage Life Insurance Company of America, Globe Life And Accident Insurance Company, Liberty National Life Insurance Company, and United American Insurance Company [4]. - The company employs over 16,000 insurance agents and 3,600 corporate employees, managing more than 17 million policies in force [4].

Company Overview - Chubb Limited, formerly known as ACE Limited, is one of the world's largest providers of property and casualty (P&C) insurance and reinsurance, with a market capitalization of $86 billion [11] - The company has diversified through acquisitions into various specialty lines, including marine, medical risk, excess property, environmental, and terrorism insurance, and operates in 54 countries and territories [11] Investment Ratings - Chubb has a Zacks Rank of 3 (Hold) and a VGM Score of B, indicating a solid position in the market [12] - The company also has a Value Style Score of B, supported by attractive valuation metrics such as a forward P/E ratio of 13.14, which may appeal to value investors [12] Earnings Estimates - In the last 60 days, 11 analysts have revised their earnings estimates upwards for fiscal 2025, with the Zacks Consensus Estimate increasing by $1.66 to $23.67 per share [12] - Chubb has demonstrated an average earnings surprise of +13.4%, indicating a positive trend in earnings performance [12] Investment Consideration - With a solid Zacks Rank and strong Value and VGM Style Scores, Chubb is recommended to be on investors' short list for potential investment opportunities [13]

Core Insights - Ethos partners with Aflac to enhance access to supplemental health insurance through a digital platform, starting with Aflac's cancer insurance offerings [1][2] Company Overview - Ethos is a leading life insurance technology company focused on democratizing access to life insurance and transforming the insurance experience through a digital-first approach [6] - Aflac is a Fortune 500 company recognized as the No. 1 provider of supplemental health insurance in the U.S. and a leading provider in Japan for cancer and medical insurance [7] Partnership Details - The collaboration allows Aflac to utilize Ethos's technology and distribution network, providing a seamless digital experience for customers to access cancer insurance [2][4] - Aflac's cancer insurance offers cash benefits directly to policyholders for medical costs and ongoing expenses during treatment, with no deductibles and straightforward claims processing [3][4] Strategic Implications - The partnership underscores Ethos's role as a key distribution and technology partner for top-rated insurers, enhancing the accessibility and affordability of insurance products for families [4][5] - Ethos aims to empower insurance carriers to modernize distribution and make essential protection simple and affordable for millions [5]